Evidence map›Paper›PMID 26060202›Full record

Trial reportEuropean heart journal. Cardiovascular Imaging2016

QRS complex distortion (Grade 3 ischaemia) as a predictor of myocardial damage assessed by cardiac magnetic resonance imaging and clinical prognosis in patients with ST-elevation myocardial infarction.

Karl-Philipp Rommel, Hadeel Badarnih, Steffen Desch, Matthias Gutberlet, Gerhard Schuler, Holger Thiele, Ingo Eitel

Registry-linked trialOpen access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in European heart journal. Cardiovascular Imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00712101 (Prospective Randomized Controlled Clinical Study to Compare Abciximab-bolus i.v. Versus i.c. in Primary PCI in Patients With Acute ST-elevation Myocardial Infarction), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00712101 phase3completednot on this map

Prospective Randomized Controlled Clinical Study to Compare Abciximab-bolus i.v. Versus i.c. in Primary PCI in Patients With Acute ST-elevation Myocardial Infarction

TypeinterventionalSponsorUniversity of LeipzigRan2008 to 2011Enrolled1,912ConditionsST-elevation Myocardial InfarctionArmsabciximab intracoronary, abciximab intravenously
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Electrocardiographic R Wave Peak Time: Correlation With the Severity of Coronary Artery Disease and Prognosis in Patients With Acute Coronary Syndrome.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Article
  3. Observational
  4. Observational
  5. Article
  6. Ischemic QRS prolongation as a biomarker of myocardial injury in STEMI patients.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Karl-Philipp RommelDepartment of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Leipzig, Germany.
Hadeel BadarnihDepartment of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Leipzig, Germany.
Steffen DeschDepartment of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Leipzig, Germany University Heart Center Lübeck, Medical Clinic II (Cardiology, Angiology, Intensive Care Medicine), Ratzeburger Allee 160, 23538 Lübeck, Germany.
Matthias GutberletDepartment of Diagnostic/Interventional Radiology, University of Leipzig-Heart Center, Leipzig, Germany.
Gerhard SchulerDepartment of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Leipzig, Germany.
Holger ThieleDepartment of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Leipzig, Germany University Heart Center Lübeck, Medical Clinic II (Cardiology, Angiology, Intensive Care Medicine), Ratzeburger Allee 160, 23538 Lübeck, Germany.
Ingo EitelDepartment of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Leipzig, Germany University Heart Center Lübeck, Medical Clinic II (Cardiology, Angiology, Intensive Care Medicine), Ratzeburger Allee 160, 23538 Lübeck, Germany ingoeitel@gmx.de.
Leipzig Heart Institute · DEUniversity of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsDistortion of the terminal portion of the QRS complex (so-called Grade 3 ischaemia, G3I) has been associated with adverse outcomes in ST-elevation myocardial infarction (STEMI) populations. However, the correlation of G3I with infarct size and microvascular injury as defined by cardiac magnetic resonance (CMR) is not well defined. Aim of this study was to assess the relation of G3I with myocardial damage as assessed by CMR and clinical outcomes in STEMI patients. METHODS AND

resultsWe analysed the ECGs of 572 consecutive STEMI patients regarding the presence or absence of G3I. CMR was performed within 1 week after infarction for comprehensive assessment of myocardial damage using a standardized protocol. The primary clinical endpoint was major adverse cardiac events (MACE) within 12 months after infarction. G3I was present in 186 (32%) patients. The presence of G3I was associated with larger infarct size (P = 0.01), the presence of late microvascular obstruction (P = 0.05), the presence of intramyocardial haemorrhage (P = 0.04), and impaired myocardial salvage (P = 0.01). G3I was associated with a higher incidence of MACE (P = 0.01) and was identified as an independent predictor of MACE in Cox regression analysis (HR 2.19; 95% CI 1.10 to 4.38, P = 0.03).

conclusionThis largest study to date correlating G3I on the admission ECG with CMR markers of myocardial damage demonstrates that G3I is significantly associated with infarct size, impaired myocardial salvage, and reperfusion injury in a reperfused STEMI population. Moreover, G3I was independently associated with MACE. CLINICALTRIALS.GOV: NCT00712101.

Indexed as

AbciximabAgedAntibodies, MonoclonalAnticoagulantsElectrocardiographyFemaleGermanyHumansImmunoglobulin Fab FragmentsKaplan-Meier EstimateMagnetic Resonance ImagingMaleMicrovesselsMiddle AgedMyocardial InfarctionMyocardial IschemiaAbciximabAntibodies, MonoclonalAnticoagulantsImmunoglobulin Fab Fragmentscardiac magnetic resonanceelectrocardiogrammyocardial infarctionprognosis

Identifiers

PMID26060202
PMCPMC4882879
OpenAlexW617342559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.